We are live on ! Find out more
DCLA

Douglas C. Lane & Associates Portfolio holdings

AUM $3.69B
1-Year Est. Return 0.11%
This Fund
S&P 500
This Quarter Est. Return
-0.45%
1 Year Est. Return
+0.11%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.35B
AUM Growth
+$41.9M
Cap. Flow
+$91.4M
Cap. Flow %
2.73%
Top 10 Hldgs %
20.42%
Holding
248
New
25
Increased
103
Reduced
91
Closed
15

Top Buys

Rank Stock Value
1
MET icon
MetLife
MET
+$14.9M
2
DINO icon
HF Sinclair
DINO
+$8.26M
3
SSYS icon
Stratasys
SSYS
+$7.67M
4
VLO icon
Valero Energy
VLO
+$7.25M
5
MPC icon
Marathon Petroleum
MPC
+$6.33M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$17.8M
2
KO icon
Coca-Cola
KO
+$6.05M
3
MMM icon
3M
MMM
+$5.98M
4
HRI icon
Herc Holdings
HRI
+$5.57M
5
WBD icon
Warner Bros
WBD
+$5.26M

Sector Composition

Rank Sector Weight
1 Industrials 19.4%
2 Technology 15.85%
3 Healthcare 15.09%
4 Consumer Discretionary 10.88%
5 Financials 5.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HSY icon
151
Hershey
HSY
$36.6B
$678K 0.02%
7,100
+1,666
+31% +$154K
MRSH
152
Marsh
MRSH
$91.5B
$650K 0.02%
12,425
-6,839
-36% -$357K
AMZN icon
153
Amazon
AMZN
$2.96T
$622K 0.02%
38,600
+5,480
+17% +$91.1K
HD icon
154
Home Depot
HD
$355B
$586K 0.02%
6,392
+1,199
+23% +$103K
ESRX
155
DELISTED
Express Scripts Holding Company
ESRX
$578K 0.02%
8,184
+120
+1% +$8.55K
C icon
156
Citigroup
C
$226B
$566K 0.02%
10,930
-7,387
-40% -$371K
MCD icon
157
McDonald's
MCD
$195B
$553K 0.02%
5,829
-181
-3% -$17.3K
UL icon
158
Unilever
UL
$136B
$547K 0.02%
11,600
-444
-4% -$21.9K
DD
159
DELISTED
Du Pont De Nemours E I
DD
$532K 0.02%
7,804
+430
+6% +$27.1K
SWK icon
160
Stanley Black & Decker
SWK
$15.7B
$524K 0.02%
+5,905
New +$528K
UNP icon
161
Union Pacific
UNP
$174B
$448K 0.01%
4,133
+1,600
+63% +$166K
NEE icon
162
NextEra Energy
NEE
$177B
$446K 0.01%
19,016
+2,072
+12% +$50K
ZBH icon
163
Zimmer Biomet
ZBH
$18.4B
$444K 0.01%
4,548
+515
+13% +$50.7K
EMC
164
DELISTED
EMC CORPORATION
EMC
$443K 0.01%
15,154
+1,734
+13% +$50K
APC
165
DELISTED
Anadarko Petroleum
APC
$435K 0.01%
4,291
+64
+2% +$6.9K
OPK icon
166
Opko Health
OPK
$1.02B
$426K 0.01%
+50,000
New +$439K
WBC
167
DELISTED
WABCO HOLDINGS INC.
WBC
$426K 0.01%
4,680
-600
-11% -$60.5K
DE icon
168
Deere & Co
DE
$168B
$425K 0.01%
5,183
+215
+4% +$18.4K
GWW icon
169
W.W. Grainger
GWW
$60.2B
$421K 0.01%
1,674
+277
+20% +$67.9K
CHK
170
DELISTED
Chesapeake Energy Corporation
CHK
$418K 0.01%
+91
New +$479K
ED icon
171
Consolidated Edison
ED
$39.8B
$413K 0.01%
+7,283
New +$413K
BIIB icon
172
Biogen
BIIB
$30.7B
$410K 0.01%
1,240
+470
+61% +$155K
CVS icon
173
CVS Health
CVS
$122B
$394K 0.01%
4,953
-900
-15% -$70.9K
COP icon
174
ConocoPhillips
COP
$141B
$386K 0.01%
5,042
+777
+18% +$63.6K
BDX icon
175
Becton Dickinson
BDX
$48.7B
$384K 0.01%
3,454
-11
-0.3% -$1.25K

Similar funds

Douglas C. Lane & Associates's Q3 2014 Portfolio in Review

As of Q3 2014, Douglas C. Lane & Associates held 248 positions worth $3.35B, up 1.3% from $3.31B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Douglas C. Lane & Associates's Q3 2014 filing shows 25 new, 103 increased, 91 reduced and 15 closed positions. Its largest new stake was Stratasys: 67,832 shares worth $8.19M. The largest sale was AbbVie, an estimated $17.8M.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Healthcare.

  • Douglas C. Lane & Associates's largest Q3 2014 buy was Stratasys: 67,832 shares worth $8.19M.
  • Douglas C. Lane & Associates added most to MetLife in Q3 2014, an estimated $14.9M increase.
  • Douglas C. Lane & Associates's biggest Q3 2014 reduction was AbbVie, cutting an estimated $17.8M.
  • Douglas C. Lane & Associates fully exited Carbo Ceramics Inc. in Q3 2014, selling an estimated $2.28M.
  • Douglas C. Lane & Associates's ten largest holdings make up 20% of its $3.35B portfolio in Q3 2014.
  • Douglas C. Lane & Associates opened 25 new positions and closed 15 in Q3 2014.
  • Douglas C. Lane & Associates's portfolio value rose 1.3% quarter-over-quarter to $3.35B.

Based on Douglas C. Lane & Associates's 13F filing for Q3 2014, filed 27 Oct 2014.